Anti-TNF-alpha Rx improves sleep quality in ankylosing spondylitis

Anti-TNF-α rx improves sleep quality in ankylosing spondylitis
(HealthDay)—Anti-tumor necrosis factor-α (TNF-α) therapy improves sleep quality (SQ) in patients with ankylosing spondylitis (AS) without any improvement in polysomnography (PSG) measures, according to a study published online May 29 in the International Journal of Rheumatic Diseases.

Gulsah Karatas, from the Karabuk University Faculty of Medicine in Turkey, and colleagues examined the correlation between SQ and disease activity (DA) in 34 patients who met the modified New York classification criteria for AS. Fifteen patients had high DA and received anti-TNF-α therapy (Group I) and 19 patients were in remission (Group II). Disorders and patterns of sleep were assessed with the Pittsburgh Sleep Quality Index (PSQI) and polysomnography (PSG), respectively, at baseline and at the third month of anti-TNF-α therapy in Group I.

The researchers found that 57.9 percent of all patients had impaired SQ in baseline evaluation. Obstructive apnea syndrome, snoring, and periodic leg movements were seen with PSG in 73.7, 74.4, and 26.3 percent of patients, respectively. Group I had significantly higher PSQI (P = 0.0001) and snoring score (P = 0.012). In Group I there was a significant reduction in PSQI scores at the third month of anti-TNF-α therapy (P = 0.005), but there was no change in PSG parameters (P > 0.05).

"Anti-TNF-α has improved SQ without any improvement in PSG," the authors write. "PSG parameters might be more associated with disease pathogenesis rather than DA in with AS."


Explore further

Certain criteria may be better than others in RA assessment

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: Anti-TNF-alpha Rx improves sleep quality in ankylosing spondylitis (2017, June 23) retrieved 24 May 2019 from https://medicalxpress.com/news/2017-06-anti-tnf-alpha-rx-quality-ankylosing-spondylitis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more